Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-044432
Filing Date
2025-03-25
Accepted
2025-03-25 16:27:50
Documents
17
Effectiveness Date
2025-03-25

Document Format Files

Seq Description Document Type Size
1 S-8 antx-20250325.htm S-8 177383
2 EX-5.1 antx-ex5_1.htm EX-5.1 21899
3 EX-23.2 antx-ex23_2.htm EX-23.2 4006
4 EX-FILING FEES antx_exfilingfees.htm   iXBRL EX-FILING FEES 72071
5 GRAPHIC img51266987_0.jpg GRAPHIC 49249
6 GRAPHIC img51266987_1.jpg GRAPHIC 18549
  Complete submission text file 0000950170-25-044432.txt   530812

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT antx_exfilingfees_htm.xml XML 19265
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286094 | Film No.: 25768688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)